US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

107.13

-0.9300-0.86%

Volume:108.44K

Turnover:11.64M

Market Cap:1.02B

PE:86.80

High:108.01

Open:107.78

Low:106.86

Close:108.06

52wk High:118.00

52wk Low:90.60

Shares:9.54M

Float Shares:9.54M

Volume Ratio:1.07

T/O Rate:1.14%

Dividend:2.14

Dividend Rate:2.00%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):137.97

Loading ...

Overview Company News Filings

Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period

THOMSON REUTERS

Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study

Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity

THOMSON REUTERS

AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period

AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal

MT Newswires Live

Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026

THOMSON REUTERS

AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO

AbbVie Shows Pipeline-Driven Upside Beyond Core Immunology Franchise, BofA Says

MT Newswires Live

Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium

MT Newswires Live

Novo Says Ozempic Cuts Risk of Major Cardiovascular Events

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)

AbbVie Partners with Valkai to Deploy AI Across Clinical Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/PPH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":107.13,"timestamp":1791212379497,"preClose":108.06,"halted":0,"volume":108439,"delay":0,"changeRate":-0.008606329816768525,"floatShares":9538138,"shares":9538138,"eps":1.234146,"marketStatus":"Trading","change":-0.93,"latestTime":"10-05 10:59:54 EDT","open":107.78,"high":108.005,"low":106.8645,"amount":11636537.039280001,"amplitude":0.010554,"askPrice":107.17,"askSize":163,"bidPrice":107.14,"bidSize":45,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.06,"sharesOutstanding":11938138,"nav":108.04699,"aum":1014360012.4,"dividendRate":0.019972,"bidAskSpread":0.000353,"preHourTrading":{"tag":"盘前","latestPrice":108.1954,"preClose":108.06,"latestTime":"08:39 EDT","volume":153,"amount":16616.96127,"timestamp":1791203968219,"change":0.1354,"changeRate":0.001253,"amplitude":0.026334},"postHourTrading":{"tag":"盘后","latestPrice":108.06,"preClose":108.06,"latestTime":"19:30 EDT","volume":40,"amount":4324.26,"timestamp":1790983847593,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.066524,"impliedVol":0.2083,"impliedVolPercentile":0.6853},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9538138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":1.066524,"shares":9538138,"dividePrice":2.1396,"high":108.005,"amplitude":0.010554,"preClose":108.06,"low":106.8645,"week52Low":90.6,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":107.13,"committee":-0.567308,"eps":1.234146,"divideRate":0.019972,"volume":108439,"delay":0,"ttmEps":1.234146,"open":107.78,"prevYearClose":103.17,"prevWeekClose":108.06,"prevMonthClose":109.47,"prevQuarterClose":109.47,"fiveDayClose":111.48,"twentyDayClose":114.21,"sixtyDayClose":108.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"PPH","amount":0.36,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-06","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-06"},{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"},{"executeDate":"2018-04-02","recordDate":"2018-04-03","paymentDate":"2018-04-06","value":0.3943,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671270785","title":"Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270785?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","IE00BBT3K403.USD","LU2087621335.USD","ABBV","LU0203347892.USD","MEDX","RXL","SG9999015952.SGD","IXJ","LU1839511570.USD","IE0004445239.USD","LU1267930490.SGD","BK4559","LU1983299246.USD","PJP","LU2129689431.USD","FHLC","BK4534","LU1236620750.USD","IYH","LU0868494617.USD","LU0058720904.USD","PPH","LU1093756168.USD","XLV","JDOC","AGNG","IE00BJJMRZ35.SGD","LU0198837287.USD","LU0124676726.USD","LU1037948897.HKD","IE0002141913.USD","IE00BGHQF631.EUR","LU0320765646.SGD","LU1934455194.USD","LU0395794307.EUR","LU1934455863.HKD","VHT","TRUH","LU0820561909.HKD","LU0234570918.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU0203345920.USD","IE000BZT7R73.USD","LU0289739343.SGD","LU0949170772.SGD","LU1244550494.USD","FTXH","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270754","title":"Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270754","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270754?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"Patients switching toNovo Nordisk's Wegovy pill from shots lose more weight in real-world studySept 30 -Patients who switched from weight-loss injections to Novo Nordisk'sNOVOb.COdaily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday, as the Danish drugmaker seeks to defend its lead over US rival Eli LillyLLY.Nin the market for oral obesity treatments.Study participants lost an average of 4.1% of their body weight over three months after transitioning from injectable obesity therapies — including Wegovy and Lilly's Zepbound — to oral semaglutide, the active ingredient in Wegovy, as well as Ozempic.Patients lost an average of 4.0 kg  from a baseline weight of 221.6 pounds  after making the switch, and the proportion of participants classified as clinically obese dropped to 65.5% from 87.1% after three months, with nearly 41% shedding at least 5% of their body weight.\"There's been a lot of questions on can people be compliant to the pill?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45L0IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","NVOX","BK4585","PPH","OZEM","BK4007","LU1093756325.SGD","THNR","NVOH","BK4532","BK4599","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270207","title":"Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270207?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015978.USD","LU0545039389.USD","LU1244550577.SGD","BK4534","LU2357627491.SGD","IE00BLSP4239.USD","BK4139","TRUH","SG9999011175.SGD","JDOC","LU1430594728.SGD","IE000SO60NU8.SGD","VHT","LU1037948897.HKD","RXL","ABBV","IYH","MEDX","IXJ","LU2237443549.SGD","LU0985320562.USD","IE0002141913.USD","AGNG","PPH","LU0395794307.EUR","BK4533","FHLC","GLAM","LU0310800379.SGD","LU2087621335.USD","LU0795875169.SGD","LU1732800096.USD","PJP","LU0689626769.HKD","LU1720051017.SGD","LU1267930573.SGD","LU2089283258.USD","LU0158827948.USD","LU2347655156.SGD","LU1989771016.USD","LU1989772840.SGD","IE000BZT7R73.USD","IE0009355771.USD","LU0289739699.SGD","XLV","IE00BSNM7G36.USD","LU0128525929.USD","FTXH","LU0943347566.SGD","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208209","title":"AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208209?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss Up To About 10% Over 3-Month PeriodSept 30 -AbbVie Inc.ABBV.N:ABBVIE: IN PHASE 1 ABBV-295 STUDY, ALL DOSING REGIMENS RESULTED IN LS MEAN WEIGHT LOSS UP TO ABOUT 10% OVER 3-MONTH TREATMENT PERIODABBVIE: 82.2% OF ALL ABBV-295 TREATED PARTICIPANTS REPORTED MILD ADVERSE EVENTS AS HIGHEST REPORTED AE SEVERITYFurther company coverage:ABBV.N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","FTXH","LU1037948897.HKD","LU1983299246.USD","LU1934455277.USD","XLV","LU0057025933.USD","LU0310799852.SGD","LU1496350502.SGD","LU0432979614.USD","LU0158827948.USD","LU1093756168.USD","LU0472753341.HKD","GLAM","LU0114720955.EUR","SG9999015978.USD","IE00BN8TJ469.HKD","FHLC","LU0820561909.HKD","SG9999015952.SGD","LU0256863902.USD","IXJ","LU0689472784.USD","PJP","IE0004445239.USD","LU0823416689.USD","MEDX","LU1839511570.USD","VHT","LU1291159041.SGD","LU1548497426.USD","PPH","LU0320765646.SGD","TRUH","LU1430594728.SGD","BK4566","LU0098860793.USD","LU2357305700.SGD","LU2089984988.USD","JDOC","IE00BSNM7G36.USD","LU0310800379.SGD","RXL","AGNG","LU1670627923.USD","LU2112291526.USD","LU0965508806.USD","ABBV","LU2087621335.USD","LU1732800096.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271707","title":"AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271707","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671271707?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:14","pubTimestamp":1790756080,"startTime":"0","endTime":"0","summary":"AbbVie's  phase 2 dose-finding study of zumilokibart in adults with moderate-to-severe atopic dermatitis met its primary endpoint, with all three dose regimens achieving \"significantly\" higher response rates at week 16, compared with placebo, the company said Wednesday.The mid-dose regimen has been selected for phase 3 development.The findings support further evaluation of the drug's efficacy, safety and extended dosing intervals as a potential long-term treatment option, AbbVie said.Atopic dermatitis is a condition that causes dry, itchy and inflamed skin.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999015945.SGD","BK4588","AGNG","LU0289739343.SGD","LU0965509101.SGD","LU1003077747.HKD","BK4534","LU0708994859.HKD","BK4550","LU1496350171.SGD","LU0456855351.SGD","PPH","GLAM","XLV","LU1720051017.SGD","IE00BFTCPJ56.SGD","VHT","IE00BVYPNW00.USD","FTXH","LU0820561909.HKD","TRUH","LU1585245621.USD","IYH","IE000WAW04H5.SGD","MEDX","LU0211328371.USD","IE000SO60NU8.SGD","LU0069063385.USD","ABBV","LU0965509010.AUD","IE00BJT1NW94.SGD","FHLC","IXJ","LU0256863811.USD","IE00BDGV0183.EUR","LU1670628061.USD","LU2357305700.SGD","LU0511384066.AUD","LU1732800096.USD","PJP","IE00BJJMRZ35.SGD","LU0943347566.SGD","LU1983299246.USD","LU2023251221.USD","RXL","JDOC","IE00B2B36J28.USD","LU1934455863.HKD","IE00BSNM7G36.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220206","title":"Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:30","pubTimestamp":1790746200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUAFW3VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","VHT","LU0820561818.USD","BK4581","IYH","JDOC","LU1037948541.HKD","LU1720051017.SGD","FHLC","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU0949170772.SGD","LU1929549753.HKD","IE00B4R5TH58.HKD","LU2125909593.SGD","IXJ","LU1718418525.SGD","TRUH","LU0170899867.USD","PJP","PPH","LU0256863902.USD","LU1093756325.SGD","LU2089284900.SGD","LU1061106388.HKD","LU0942090050.USD","LU1551013425.SGD","LU0708994859.HKD","RXL","ABBV","IE0009355771.USD","GLAM","FTXH","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999015986.USD","XLV","LU0511384066.AUD","LU1496350171.SGD","LU1670627923.USD","BK4550","LU1496350502.SGD","LU2347655156.SGD","LU0472753341.HKD","LU1162221912.USD","LU0738911758.USD","AGNG","LU2125909247.SGD","LU1548497426.USD","LU1003077747.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220398","title":"AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220398?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:01","pubTimestamp":1790744482,"startTime":"0","endTime":"0","summary":"AbbVie presents Phase 2 APEX Part B data for zumilokibart in moderate-to-severe atopic dermatitis at EADV 2026AbbVie flagged new dermatology trial and real-world results slated for presentation at the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL524zqn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU1496350171.SGD","LU1291159041.SGD","JDOC","IE00B19Z3581.USD","LU1074936037.SGD","LU0661504455.SGD","LU2357627491.SGD","LU2237443382.USD","LU2089284900.SGD","XLV","IE000SO60NU8.SGD","IE000F7OJYX1.SGD","LU1934455863.HKD","LU0320765646.SGD","MEDX","LU2347655073.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU1244550494.USD","PPH","SG9999015952.SGD","LU0472753341.HKD","LU2468319806.SGD","LU2089283258.USD","LU0738911758.USD","RXL","IXJ","LU1061106388.HKD","PJP","LU1934455277.USD","LU0098860793.USD","LU0795875086.SGD","LU0949170772.SGD","LU2133065610.SGD","LU1057294990.SGD","FHLC","GLAM","TRUH","LU0289739699.SGD","IYH","LU0689472784.USD","LU1585245621.USD","LU1718418525.SGD","FTXH","AGNG","ABBV","LU1923622614.USD","LU2237443895.HKD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224004","title":"Eli Lilly reports results from TRIUMPH-2 Phase 3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224004","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224004?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:10","pubTimestamp":1790719814,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0640476718.USD","LU0316494557.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2750360997.AUD","VHT","LU1712237335.SGD","LU2462157665.USD","LU1983299246.USD","IE00BN29S564.USD","LU0158827948.USD","LU0109391861.USD","LU0174119429.USD","LU0889565916.HKD","IE00B1XK9C88.USD","PJP","LU1366192091.USD","LU0345770308.USD","CANC","LU1127390331.HKD","LU1145028129.USD","LU2361044865.SGD","LU2896262040.SGD","LU2471134952.CNY","LU2491050071.SGD","SG9999001176.USD","LU0354030438.USD","LU0432979614.USD","LU1804176565.USD","SGXZ31699556.SGD","LU0823434740.USD","LLY","LU1551013425.SGD","LU2168564495.EUR","LU2063271972.USD","LU2357305700.SGD","LU0683600562.USD","LU0786609619.USD","LU1069344957.HKD","LU1691799644.USD","LU1323610961.USD","IHE","LU2264538146.SGD","LU2361044949.HKD","LU0823416689.USD","LU0256863902.USD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","IXJ","LU0353189680.USD","TRUH","IYH","THNR","LU2552382215.SGD","IE00B2B36J28.USD","LU1629891620.HKD","BK4533","LU0353189763.USD","LU0882574139.USD","LU2028103732.USD","LU2168564149.EUR","LU1023059063.AUD","LU0225283273.USD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1868836591.USD","SGXZ51526630.SGD","LU1868836914.USD","LU2468319806.SGD","LU0471298777.SGD","SG9999014880.SGD","SG9999018857.SGD","LU0058720904.USD","LU2237443622.USD","LU0943347566.SGD","MEDI","SGXZ99366536.SGD","LU0823434583.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0234572021.USD","IE0001KFT4U8.USD","LU0106261372.USD","LU1720051108.HKD","LU2023251221.USD","LU2112291526.USD","LU0079474960.USD","IE00B775H168.HKD","SG9999017495.SGD","LU1093756325.SGD","LU1280957306.USD","LU2324357040.USD","LU2746668974.SGD","BK4534","LU2461242641.AUD","LU1064131342.USD","LU2237438978.USD","LU2236285917.USD","LU0094547139.USD","PPH","LU1868837300.USD","OZEM","LU1232071149.USD","LU0456855351.SGD","SG9999013999.USD","LU0096364046.USD","LU0820561818.USD","SG9999014906.USD","BK4599","LU0109394709.USD","LU0417517546.SGD","LU2552382058.USD","LU0203202063.USD","LU0964807845.USD","LU1061106388.HKD","LU1551013342.USD","LU2746668461.USD","LU2089984988.USD","LU0471298694.HKD","SG9999001176.SGD","LU1035775433.USD","XLV","LU2237443465.HKD","LU2237443549.SGD","SG9999015986.USD","SG9999014898.SGD","AGNG","LU0238689110.USD","LU1623119135.USD","IE00BJJMRX11.SGD","IE0004445239.USD","LU0385154629.USD","BK4581","HRTS","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU2360106947.USD","LU2265009873.SGD","LU2271345857.HKD","LU2602419157.SGD","GB00BDT5M118.USD","LU2552382132.HKD","SGXZ57979304.SGD","SGXZ81514606.USD","LU2237443382.USD","LU0256863811.USD","LU2237443895.HKD","LU2491050154.USD","BK4516","LU2456880835.USD","LU1057294990.SGD","LU0689472784.USD","IE00BK4W5L77.USD","GDOC","LU1868837136.USD","MEDX","LU1267930730.SGD","LLYX","LU1979441026.SGD","IE0002141913.USD","LU2023250330.USD","LU0006306889.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU2491049909.HKD","JDOC","LU0354030511.USD","LU0672654240.SGD","LU2471134796.USD","RXL","LU1988902786.USD","SG9999015945.SGD","LU1720051017.SGD","BK4585","LU0820562030.AUD","LU0266013472.USD","LU2168563687.JPY","LU2361045086.USD","SG9999015978.USD","LU1989771016.USD","LU0097036916.USD","FTXH","LU0122379950.USD","LU0320765992.SGD","LU2471134879.HKD","TMED","LU0708995401.HKD","LLII","LU2087625088.SGD","LU0133085943.USD","IE0009355771.USD","LU1868836757.USD","SG9999018865.SGD","LU2089283258.USD","LU2417539215.USD","LU0320765059.SGD","WDNA","LU2756315664.SGD","MHIP","LU2462591350.SGD","LU0203201768.USD","FHLC","LU0882574055.USD","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU1814569148.SGD","IE0005OL40V9.USD","LU2089284900.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","LU0061475181.USD","LLYZ","LU0323591593.USD","LU1548497426.USD","ILDR","LU0198837287.USD","LU0820561909.HKD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU2211815571.USD","SG9999014914.USD","ELIL","LU0787776722.HKD","BK4588","SG9999015952.SGD","LU0345770993.USD","CURE","IE0004445015.USD","LU2168564222.USD","LU2471134523.USD","IE00BK4W5M84.HKD","LU1093756168.USD","LU2106854487.HKD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0158827781.USD","LU2111349929.HKD","BK4007","LU0210536198.USD","LU2750360641.GBP","ELIS","IE00BJLML261.HKD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671402792","title":"Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671402792","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671402792?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:06","pubTimestamp":1790719599,"startTime":"0","endTime":"0","summary":"Lilly's experimental drug cuts weight by 21% in diabetes trialSept 29 (Reuters)-Eli LillyLLY.Nsaid on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L216:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU2023250504.SGD","FHLC","LU2108987350.USD","LU1069344957.HKD","SGXZ81514606.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU2089283258.USD","VHT","TMED","LU0345770993.USD","LU0787776722.HKD","LU2023250330.USD","LU2471134796.USD","ELIS","XLV","IE0004445239.USD","LU1868837300.USD","IHE","LU0109394709.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LU0353189680.USD","LU2089984988.USD","LU0289739699.SGD","LU2023251221.USD","MHIP","OZEM","LU0466842654.USD","LU2552382058.USD","IE00B775H168.HKD","LLYX","SG9999014906.USD","LU0096364046.USD","LU1548497426.USD","LU0061475181.USD","LU1868836914.USD","LU0640476718.USD","IE00B2B36J28.USD","LU2168564222.USD","LU2168564495.EUR","SG9999018865.SGD","SGXZ31699556.SGD","LU2462157665.USD","LU0097036916.USD","LU0417517546.SGD","LU0354030511.USD","IE0005OL40V9.USD","LU0109391861.USD","LU1064131342.USD","BK4516","LU2471134523.USD","LU2552382132.HKD","LU0456855351.SGD","IE00BFSS7M15.SGD","LU1366192091.USD","IE0002141913.USD","LU1551013342.USD","LLII","LU0943347566.SGD","LU0058720904.USD","LU0823434740.USD","LU0256863902.USD","LU2028103732.USD","LU1035775433.USD","IE00BWXC8680.SGD","LU0471298777.SGD","LU1127390331.HKD","IE00BKDWB100.SGD","LU2471134879.HKD","RXL","LU2087625088.SGD","LU2357305700.SGD","LU1061106388.HKD","LU2602419157.SGD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU0114720955.EUR","LU1623119135.USD","LU0320765059.SGD","LU2491050071.SGD","LU2360106947.USD","LU0683600562.USD","LU0266013472.USD","LU2896262040.SGD","LU1720051108.HKD","SG9999014898.SGD","LU0256863811.USD","LU1291159041.SGD","SG9999014880.SGD","LU2324357040.USD","LU2750360641.GBP","SG9999001176.SGD","IE00B4JS1V06.HKD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU0820561909.HKD","SG9999014914.USD","LU0882574055.USD","LU2237438978.USD","LU0882574139.USD","LLYZ","IE00BJJMRY28.SGD","GB00BDT5M118.USD","LU1983299246.USD","BK4585","LU1093756325.SGD","LU2237443978.SGD","MEDX","CURE","LU2756315318.SGD","LU0203201768.USD","LU2211815571.USD","SG9999015945.SGD","TRUH","BK4533","LU0210536198.USD","LU2750360997.AUD","LU0889565916.HKD","LU0820562030.AUD","IE0004445015.USD","LU0158827781.USD","SG9999001176.USD","IE00B1XK9C88.USD","LU2112291526.USD","BK4534","LU2237443465.HKD","IE00BK4W5M84.HKD","IE00BN29S564.USD","WDNA","CANC","SG9999017495.SGD","LU1988902786.USD","LU0471298694.HKD","LU1974910355.USD","LU0006306889.USD","LU0122379950.USD","LU0238689110.USD","LU0385154629.USD","LU1629891620.HKD","LU1145028129.USD","LU1917777945.USD","LU1989771016.USD","LU2237443622.USD","SG9999015952.SGD","LU2168563687.JPY","LU1868836591.USD","LU1280957306.USD","LU0198837287.USD","LU2491049909.HKD","IE0001KFT4U8.USD","LU2264538146.SGD","LU2462591350.SGD","LU1057294990.SGD","ELIL","LU1691799644.USD","LU0823416689.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0345770308.USD","IE0009355771.USD","LU0158827948.USD","LU0689472784.USD","LU2089284900.SGD","LU2111349929.HKD","LU2361045086.USD","SGXZ99366536.SGD","LU0079474960.USD","LU1093756168.USD","LU2237443895.HKD","IE00BJLML261.HKD","LU1551013425.SGD","SG9999015986.USD","FTXH","LU2461242641.AUD","LU0106261372.USD","LU2237443549.SGD","LU0786609619.USD","GDOC","LU0353189763.USD","IYH","LU0323591593.USD","LU2213496289.HKD","LU0234572021.USD","BK4588","LU1804176565.USD","LU1868837136.USD","LU0820561818.USD","LU2237443382.USD","LU2265009873.SGD","LU0133085943.USD","LU0316494557.USD","SG9999013999.USD","LU2456880835.USD","LU2361044949.HKD","LU0320765992.SGD","HRTS","LU2063271972.USD","LU0174119429.USD","BK4007","IXJ","LU1023059063.AUD","LU2468319806.SGD","LU2746668461.USD","LU0354030438.USD","LU2106854487.HKD","LU0672654240.SGD","IE00B7KXQ091.USD","LU1720051017.SGD","MEDI","PJP","LU2471134952.CNY","JDOC","LLY","LU0094547139.USD","LU1979441026.SGD","LU2168564149.EUR","LU0964807845.USD","LU1323610961.USD","LU0225283273.USD","ILDR","LU1814569148.SGD","LU0432979614.USD","LU2491050154.USD","PPH","SG9999015978.USD","SG9999018857.SGD","LU2361044865.SGD","BK4599","LU2756315664.SGD","AGNG","IE00BKPKM429.USD","LU2271345857.HKD","LU1712237335.SGD","LU2236285917.USD","SGXZ51526630.SGD","LU0203202063.USD","LU1868836757.USD","LU2746668974.SGD","LU2417539215.USD","LU2168564065.EUR","IE00BJJMRX11.SGD","BK4581","IE00BJT1NW94.SGD","THNR","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671446240","title":"Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671446240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671446240?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240445","title":"Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240445?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0006306889.USD","SG9999018865.SGD","LU0471298777.SGD","LU1974910355.USD","LU0058720904.USD","LU1979441026.SGD","LU2168564065.EUR","LU2023251221.USD","LU1064131342.USD","TRUH","LU0820562030.AUD","JDOC","LU0094547139.USD","LU1868836757.USD","IE00B4JS1V06.HKD","LU2168563687.JPY","LU1983299246.USD","LU2361045086.USD","SGXZ81514606.USD","LU2168564495.EUR","LU2265009873.SGD","LU1720051108.HKD","CURE","LU0225283273.USD","LU0787776722.HKD","SG9999014914.USD","LU1712237335.SGD","SG9999014880.SGD","LU2108987350.USD","LU0133085943.USD","LU1917777945.USD","MHIP","LU2462157665.USD","LU0266013472.USD","GB00BDT5M118.USD","LLYZ","LU1145028129.USD","LU2112291526.USD","LU2357305700.SGD","LU0238689110.USD","LU1280957306.USD","SGXZ31699556.SGD","LU2089284900.SGD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2063271972.USD","LU2896262040.SGD","LU2491050154.USD","SGXZ99366536.SGD","BK4516","LU0122379950.USD","LU0316494557.USD","ELIS","TMED","SG9999017495.SGD","IE0004445239.USD","LU0096364046.USD","LU2602419157.SGD","LU2360106947.USD","LU2106854487.HKD","LU2462591350.SGD","IE00BFSS8Q28.SGD","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","SG9999015978.USD","IE00BWXC8680.SGD","IE00B775H168.HKD","LU2264538146.SGD","LU0109394709.USD","LU2237443622.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1804176565.USD","LU2087625088.SGD","LU2236285917.USD","LU0354030511.USD","LU1323610961.USD","LU2211815571.USD","WDNA","SG9999018857.SGD","VHT","LU1988902786.USD","SG9999014898.SGD","IE00B1XK9C88.USD","LU0256863811.USD","LU1366192091.USD","PPH","FHLC","LLII","ELIL","LU2089984988.USD","SG9999015952.SGD","LU2213496289.HKD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","LU0683600562.USD","IE00BJJMRX11.SGD","LU0820561909.HKD","IE00BFTCPJ56.SGD","SGXZ51526630.SGD","LU0158827948.USD","LU2168564222.USD","GDOC","IE0009355771.USD","LU0345770308.USD","LU0289739699.SGD","LU0466842654.USD","LU2237443382.USD","LU0114720955.EUR","LU0708995401.HKD","LU0882574055.USD","LU0210536198.USD","LU0882574139.USD","MEDI","LU0943347566.SGD","LU1868837300.USD","IE0001KFT4U8.USD","LU0256863902.USD","LU2471134796.USD","LU0061475181.USD","LU2028103732.USD","BK4585","LU1057294990.SGD","LU1868836591.USD","LU2471134523.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU1127390331.HKD","LU1814569148.SGD","LU0079474960.USD","LU1267930730.SGD","LU2756315664.SGD","MEDX","IXJ","BK4588","LU0203202063.USD","LU0432979614.USD","LU1061106388.HKD","LU2491050071.SGD","LU0203201768.USD","BK4533","LU0353189680.USD","LU1023059063.AUD","LU1232071149.USD","IE00BK4W5M84.HKD","LU2456880835.USD","LU1093756325.SGD","LU0417517546.SGD","IE00B7KXQ091.USD","LU2417539215.USD","IE00BN29S564.USD","LU2023250330.USD","LU1551013342.USD","LU1868836914.USD","IE00BFSS7M15.SGD","ILDR","LU0823416689.USD","LU2089283258.USD","THNR","IE00BK4W5L77.USD","LU0964807845.USD","LU2111349929.HKD","LU0471298694.HKD","HRTS","LU0786609619.USD","LU1868837136.USD","XLV","LU1035775433.USD","LU0234572021.USD","LU0889565916.HKD","FTXH","LU0823434583.USD","LU0820561818.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","SG9999015945.SGD","LU2023250504.SGD","LU2324357040.USD","LU1551013425.SGD","BK4534","LU0672654240.SGD","LU1629891620.HKD","LU2746668974.SGD","LU2750360997.AUD","IE0004445015.USD","CANC","IE00B4R5TH58.HKD","IE00BKDWB100.SGD","LU0320765992.SGD","LU1548497426.USD","LU1691799644.USD","LU2168564149.EUR","BK4599","BK4581","LU0320765059.SGD","RXL","SG9999001176.SGD","IYH","LU0354030438.USD","LU2237443549.SGD","IE0002141913.USD","AGNG","LU0640476718.USD","LU2271345857.HKD","LU0174119429.USD","LU0158827781.USD","LU2468319806.SGD","LU0385154629.USD","LU2756315318.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0198837287.USD","SG9999015986.USD","IHE","LU2746668461.USD","PJP","LU2552382058.USD","LU1291159041.SGD","SG9999001176.USD","LU1623119135.USD","LU2491049909.HKD","LU2552382215.SGD","LU0689472784.USD","LU2237443465.HKD","SG9999013999.USD","IE00BJLML261.HKD","LLYX","LU2471134879.HKD","LU1989771016.USD","IE0005OL40V9.USD","LU0097036916.USD","LU2361044949.HKD","LU2237438978.USD","LLY","LU0106261372.USD","BK4007","LU0109391861.USD","OZEM","LU0353189763.USD","LU0323591593.USD","LU2461242641.AUD","LU2237443895.HKD","LU0823434740.USD","SG9999014906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240410","title":"Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240410?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","LU0823416689.USD","LU0289739699.SGD","IE00B775H168.HKD","LU2236285917.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU1989771016.USD","LU1548497426.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240400","title":"Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240400?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2361044865.SGD","LU1712237335.SGD","SG9999017495.SGD","IXJ","LU1720051017.SGD","LU2063271972.USD","IE00B4JS1V06.HKD","LU0174119429.USD","LU0353189763.USD","LU1629891620.HKD","LU2756315318.SGD","LU0820561909.HKD","LU2023250504.SGD","LU0385154629.USD","SG9999015945.SGD","LU0061475181.USD","VHT","LU2111349929.HKD","LU1983299246.USD","LU1974910355.USD","IE0001KFT4U8.USD","LU2746668461.USD","LU0238689110.USD","LU2168564065.EUR","LU0109391861.USD","LU2746668974.SGD","ILDR","LU2552382215.SGD","OZEM","LU1917777945.USD","LU0345770308.USD","IE0009355771.USD","LU1804176565.USD","IE00BWXC8680.SGD","LU0109394709.USD","GDOC","BK4007","CANC","IYH","LU2089284900.SGD","LU0094547139.USD","SG9999014898.SGD","LU1868836757.USD","LU2237443978.SGD","LU1280957306.USD","LU2236285917.USD","LLY","LU0820562030.AUD","LU0323591593.USD","LU2491050071.SGD","LU2602419157.SGD","LU0640476718.USD","SG9999001176.USD","LU0256863902.USD","IE00B1BXHZ80.USD","LU2023250330.USD","LU2471134879.HKD","LU2168564149.EUR","LU1720051108.HKD","LU0889565916.HKD","LU1814569148.SGD","LU0882574055.USD","LU0158827948.USD","LU2324357040.USD","LU2361045086.USD","LU0320765992.SGD","TRUH","LU0114720955.EUR","IE00BFSS7M15.SGD","SGXZ31699556.SGD","LU1551013342.USD","LU2471134796.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2471134523.USD","SG9999018857.SGD","SG9999015986.USD","LU0943347566.SGD","LU1989771016.USD","SG9999014906.USD","XLV","LU2491049909.HKD","LU1127390331.HKD","LU1366192091.USD","LU0058720904.USD","LU0823416689.USD","LU1267930730.SGD","BK4588","LU1061106388.HKD","LU2023251221.USD","LU2552382132.HKD","LLYX","IE00B4R5TH58.HKD","LU0006306889.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0354030511.USD","LU2237443549.SGD","IE00BK4W5L77.USD","THNR","LU0823434740.USD","CURE","LLII","LU0786609619.USD","LU0096364046.USD","LU2237443622.USD","ELIS","LU0689472784.USD","LU0256863811.USD","LU2213496289.HKD","LU2462157665.USD","IE00BJT1NW94.SGD","SG9999014914.USD","WDNA","LU1979441026.SGD","LU2461242641.AUD","LU2896262040.SGD","IE00B7KXQ091.USD","LU0158827781.USD","PPH","JDOC","LU2271345857.HKD","LU2089283258.USD","LU2237443382.USD","LU2552382058.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU0787776722.HKD","LU0823434583.USD","SG9999015952.SGD","LU1093756168.USD","LU1323610961.USD","LU0708995401.HKD","LU2360106947.USD","SG9999018865.SGD","LU0198837287.USD","LU2264538146.SGD","LU2750360997.AUD","LU2471134952.CNY","IE00BKPKM429.USD","IE00BKDWB100.SGD","LU1551013425.SGD","SG9999014880.SGD","LU0432979614.USD","LU2112291526.USD","LU0316494557.USD","BK4534","MEDX","RXL","SGXZ99366536.SGD","LLYZ","LU1868837300.USD","BK4581","LU0289739699.SGD","FHLC","LU1145028129.USD","LU2456880835.USD","IE00BK4W5M84.HKD","LU2265009873.SGD","LU1232071149.USD","ELIL","LU2237443895.HKD","LU2468319806.SGD","LU1868836914.USD","LU2462591350.SGD","LU2750360641.GBP","PJP","MHIP","LU2168563687.JPY","FTXH","LU0345770993.USD","IE00B775H168.HKD","SG9999015978.USD","LU0133085943.USD","LU0683600562.USD","LU2237438978.USD","LU1868836591.USD","BK4516","IE00BJJMRX11.SGD","LU0106261372.USD","LU0210536198.USD","TMED","LU1868837136.USD","LU0466842654.USD","LU0320765059.SGD","LU2756315664.SGD","SG9999001176.SGD","IE0004445015.USD","LU0097036916.USD","LU2491050154.USD","LU2168564222.USD","LU1064131342.USD","LU0353189680.USD","LU0672654240.SGD","LU2089984988.USD","LU1548497426.USD","LU0354030438.USD","LU0266013472.USD","BK4599","IE00B1XK9C88.USD","SGXZ81514606.USD","LU1069344957.HKD","BK4585","LU0203202063.USD","LU0882574139.USD","LU1035775433.USD","LU0203201768.USD","IE0002141913.USD","BK4533","LU0820561818.USD","LU1691799644.USD","IE00BN29S564.USD","LU2028103732.USD","HRTS","LU2357305700.SGD","LU2361044949.HKD","LU0964807845.USD","GB00BDT5M118.USD","LU2211815571.USD","MEDI","LU0079474960.USD","LU0456855351.SGD","SGXZ51526630.SGD","LU1057294990.SGD","IHE","LU2168564495.EUR","LU1623119135.USD","LU2417539215.USD","LU2108987350.USD","IE00BJJMRY28.SGD","LU0417517546.SGD","AGNG","LU1291159041.SGD","LU1988902786.USD","LU2106854487.HKD","SG9999013999.USD","IE00BJLML261.HKD","LU0234572021.USD","LU0471298694.HKD","IE00BFSS8Q28.SGD","LU2237443465.HKD","IE0005OL40V9.USD","LU1023059063.AUD","LU2087625088.SGD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247344","title":"AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247344","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247344?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:31","pubTimestamp":1790713860,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  slipped 1.12% to $263.29 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,670.84 and Dow Jones Industrial Average  falling 0.26% to 51,349.92.AbbVie Inc. closed 2.26% short of its 52-week high of $269.39, which the company reached on September 23rd.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.61% to $267.57, Pfizer Inc.  remained unchanged, and Amgen Inc.  rose 1.32% to $423.64.Trading volume  remained 775,865 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU1548497426.USD","LU2125909247.SGD","IE00B3PB1722.GBP","LU0726765562.USD","SG9999001440.SGD","LU1732800096.USD","LU0234570918.USD","SG9999015978.USD","VHT","SG9999011175.SGD","ABBV","LU0985320562.USD","LU0256863902.USD","LU1244550494.USD","LU1989771016.USD","IE00B4R5TH58.HKD","LU0310800379.SGD","FHLC","LU2133065610.SGD","LU0965509010.AUD","LU0912757837.SGD","LU1244550577.SGD","LU0310799852.SGD","IE00BLSP4452.SGD","LU1037948541.HKD","BK4588","LU0320765646.SGD","LU0069063385.USD","LU0289961442.SGD","LU2347655073.USD","LU1923622614.USD","LU0124676726.USD","LU0029864427.USD","LU1074936037.SGD","LU0820561818.USD","LU1267930573.SGD","SG9999015986.USD","LU1585245621.USD","LU0098860793.USD","LU2357305700.SGD","LU0057025933.USD","LU0289739343.SGD","IE00BDGV0183.EUR","SG9999015952.SGD","LU0128525929.USD","IE00BJT1NW94.SGD","LU2023251221.USD","IE0009355771.USD","IE000WAW04H5.SGD","LU0114720955.EUR","LU1934455277.USD","LU2468319806.SGD","LU2087621335.USD","BK4585","IE00BJJMRZ35.SGD","IYH","LU0882574055.USD","LU0432979614.USD","LU2237443622.USD","LU1093756325.SGD","BK4559","LU1839511570.USD","LU0820561909.HKD","LU2237443465.HKD","LU0943347566.SGD","TRUH","LU0122379950.USD","LU0795875169.SGD","MEDX","LU1037948897.HKD","LU0965509101.SGD","LU1989772840.SGD","LU0859254822.USD","LU2125909593.SGD","LU2357627491.SGD","IE00BBT3K403.USD","LU1061106388.HKD","IE00BVYPNW00.USD","LU2089284900.SGD","PPH","LU2237443549.SGD","IE00B42XCP33.USD","LU1720051017.SGD","LU2129689514.USD","LU1236620834.HKD","BK4139","LU0689472784.USD","IE00BN8TJ469.HKD","LU2089984988.USD","IE00BVYPNV92.GBP","LU1003077747.HKD","SG9999003800.SGD","LU1934455863.HKD","RXL","LU1670627923.USD","LU2237443895.HKD","LU1989772923.USD","GLAM","LU1236620750.USD","BK4566","LU0211327993.USD","LU0708994859.HKD","BK4534","IE00B19Z3B42.SGD","LU0868494617.USD","FTXH","LU0553294199.USD","LU0965509283.SGD","LU1244550221.USD","LU0395794307.EUR","XLV","JDOC","IE000MB6IJN5.SGD","BK4550","LU0868494708.USD","IXJ","LU1496350171.SGD","LU0795875086.SGD","LU0861579265.USD","LU0417517546.SGD","AGNG","LU0203345920.USD","LU0211328371.USD","LU0545039389.USD","IE00B19Z3581.USD","LU1162221912.USD","IE000F7OJYX1.SGD","LU1496350502.SGD","LU1934455194.USD","LU1983299246.USD","BK4533","LU1093756168.USD","LU1551013342.USD","LU2089283258.USD","LU1670628061.USD","IE00BFTCPJ56.SGD","LU1732799900.SGD","LU2347655156.SGD","IE00BSNM7G36.USD","IE0004445239.USD","LU0256863811.USD","LU0170899867.USD","LU0158827948.USD","BK4581","LU1718418525.SGD","LU0965508806.USD","LU0289739699.SGD","LU0738911758.USD","LU0942090050.USD","LU2129689431.USD","LU0058720904.USD","LU0456855351.SGD","LU0689626769.HKD","LU0949170772.SGD","LU1267930490.SGD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0661504455.SGD","LU2112291526.USD","LU2237443382.USD","LU0198837287.USD","IE0002141913.USD","LU1057294990.SGD","IE000BZT7R73.USD","LU1430594728.SGD","LU1551013425.SGD","LU0823416689.USD","SG9999015945.SGD","PJP","LU2237443978.SGD","LU1291159041.SGD","LU0511384066.AUD","LU1720051108.HKD","IE00BGHQF631.EUR","LU0203347892.USD","IE00B2B36J28.USD","LU2433249047.HKD","IE0000B7K699.USD","LU0234572021.USD","IE0002270589.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU2129689605.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671424110","title":"US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2671424110","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671424110?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:18","pubTimestamp":1790705925,"startTime":"0","endTime":"0","summary":"US drug lobby group PhRMA names former House leader Cantor as CEOSept 29 -The US pharmaceutical lobby group Pharmaceutical Research and Manufacturers of America said on Tuesday it had named former US House Majority Leader Eric Cantor as its next president and chief executive officer.Cantor, who served in the US House of Representatives from 2000 to 2014, will take over on November 9, PhRMA said.He succeedsStephen J. Ubl, who has led the organization since 2015,a period in which the pharmaceutical industry faced pressure from US administrations and lawmakers over prescription drug pricing, market access and regulation.PhRMA credited Cantor with backing the Medicare Part D prescription drug program, rare pediatric disease research funding and the 21st Century Cures Act during his time in Congress.Rob Davis, PhRMA board chair and CEO of MerckMRK.N, said in astatement that Cantor had experience in business, policy and politics.Ubl will remain as a strategic adviser until mid-January 2027 t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L1OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0965509283.SGD","LU0266013472.USD","LU0511384066.AUD","IE00BBT3K403.USD","IXJ","LU0432979614.USD","LU1116320901.HKD","LU2324357040.USD","LU1037948897.HKD","LU0098860793.USD","LU0823416689.USD","LU1116320737.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0162691827.USD","LU1162221912.USD","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","BK4585","BMED","IE00BJT1NW94.SGD","LU1974910355.USD","LU1035773651.USD","LU1023059063.AUD","LU0211331839.USD","LU0942090050.USD","LU0689626769.HKD","LU0203345920.USD","BK4007","LU1066053197.SGD","LU1934455194.USD","LU0289961442.SGD","LU0868494617.USD","IYH","LU2361044949.HKD","LU0861579265.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","LU2106854487.HKD","SG9999014542.SGD","LU2361045086.USD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU1941712264.USD","VHT","LU2112291526.USD","BK4516","IE00B2B36J28.USD","LU0069063385.USD","LU0057025933.USD","IE0009355771.USD","TRUH","LU0234572021.USD","BK4588","LU0980610538.SGD","LU0006306889.USD","LU1066051498.USD","SG9999014575.USD","HRTS","LU0320765489.SGD","LU1430594728.SGD","LU1093756168.USD","SG9999001176.USD","LU2125154935.USD","LU0130517989.USD","LU0203347892.USD","LU1093756325.SGD","LU2491050071.SGD","LU1934455863.HKD","LU0122379950.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1057294990.SGD","LU0477156953.USD","LU0238689110.USD","LU2360032135.SGD","LU1923622614.USD","LU2023250843.SGD","LU1037948541.HKD","SG9999001440.SGD","LU1201861249.SGD","SG9999014567.USD","LU0265550359.USD","LU1699723380.USD","LU0472753341.HKD","LU2461242641.AUD","LU2125154778.USD","FTXH","LU1032466523.USD","LU0965509101.SGD","LU2468319806.SGD","LU1571399168.USD","LU1585245621.USD","SG9999014559.SGD","SG9999002224.SGD","FHLC","LU0124676726.USD","LU0058720904.USD","LU2491050154.USD","MRK","IE000M9KFDE8.USD","BK4534","IE00BLSP4239.USD","LU2433249047.HKD","LU0648001328.SGD","LU1917777945.USD","LU2089984988.USD","LU0289739343.SGD","PPH","LU0965509010.AUD","RXL","LU0868494708.USD","LU1929549753.HKD","LU1989772923.USD","LU1989771016.USD","LU2125909593.SGD","PAWZ","LU1066051811.HKD","LU1941712348.USD","IHE","IE00BFTCPJ56.SGD","LU2361044865.SGD","LU0859254822.USD","LU2357627491.SGD","LU0265550946.USD","BK4533","LU2125909247.SGD","SG9999002232.USD","XLV","BK4550","LU0072461881.USD","LU0985320562.USD","LU0965508806.USD","LU1983299246.USD","LU2023250504.SGD","IE00BN8TJ469.HKD","LU0106261372.USD","LU1989772840.SGD","SG9999015358.SGD","LU0208291251.USD","SG9999015341.SGD","LU0130102774.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671524591","title":"AbbVie Shows Pipeline-Driven Upside Beyond Core Immunology Franchise, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2671524591","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671524591?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:49","pubTimestamp":1790696980,"startTime":"0","endTime":"0","summary":"AbbVie  shows pipeline-driven upside beyond the core immunology franchise, with outlook for its oncology and neuroscience segments likely becoming clearer over the next one to two years, BofA said in a Tuesday research note.In oncology, the company's antibody-drug conjugate portfolio, particularly temab-A and ABBV-969, have shown encouraging early efficacy and can exceed expectations if later-stage studies are successful, according to the note.Meanwhile, in neuroscience, growth has been supported by products related to Parkinson's disease, migraine, and botox therapeutic, BofA said, adding that the loss of exclusivity for Vraylar limits longer-term category growth.BofA reiterated its buy rating with a $289 price target.Price: 263.09, Change: -3.19, Percent Change: -1.20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABBV","LU2023251221.USD","LU1551013425.SGD","IE0002270589.USD","LU1929549753.HKD","VHT","TRUH","LU1244550577.SGD","LU0211327993.USD","LU1236620834.HKD","JDOC","GLAM","LU0289739343.SGD","IE00BJT1NW94.SGD","PPH","AGNG","LU0029864427.USD","LU1551013342.USD","LU0198837287.USD","FHLC","BK4533","LU1291159041.SGD","LU1989771016.USD","LU0820561909.HKD","LU0795875086.SGD","LU2125909593.SGD","BK4581","LU0310800379.SGD","LU0114720955.EUR","IE00B19Z3581.USD","LU2125909247.SGD","LU2112291526.USD","LU2347655073.USD","IYH","RXL","FTXH","IE00BFTCPJ56.SGD","BK4550","IXJ","XLV","LU0417517546.SGD","PJP","LU1074936037.SGD","LU0661504455.SGD","LU2237443978.SGD","MEDX","IE00BDGV0183.EUR","LU1496350171.SGD","LU0553294199.USD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671142248","title":"Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2671142248","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671142248?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:31","pubTimestamp":1790692316,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks'  Datapoints and Apheris said Tuesday that AbbVie , argenx , Lundbeck, and Takeda  will join them as founding members of the Antibody Developability Consortium.The consortium is designed to help pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field's largest standardized antibody developability dataset, according to a statement.The companies said that each founding member will contribute proprietary antibody sequences, with Ginkgo Datapoints filling any remaining capacity from publicly available sources to reach a total of 10,000 antibodies.The consortium is targeting an initial dataset by early 2027, they added.Price: 11.01, Change: +0.55, Percent Change: +5.26","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VHT","LU0868494708.USD","XLV","LU1670627923.USD","PPH","IBB","BK4534","IE00BJT1NW94.SGD","LU1670628061.USD","AGNG","LU1061106388.HKD","IE0004445239.USD","FHLC","TRUH","LU0128525929.USD","IE0002270589.USD","LU1585245621.USD","LU0320765646.SGD","MEDX","LU0889565916.HKD","GLAM","SG9999015945.SGD","DNA.AU","IE00BSNM7G36.USD","IYH","IE000BZT7R73.USD","JDOC","ARGX","BK4007","LU1732800096.USD","BK4533","RXL","IE00B3PB1722.GBP","FMED","LU0689472784.USD","IE0002141913.USD","PJP","IE00B42XCP33.USD","LU0211327993.USD","LU2357627491.SGD","LU0661504455.SGD","ABBV","TBXU","DNA","IE00BGHQF631.EUR","TAK","IXJ","LU2023251221.USD","FTXH","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671321075","title":"Novo Says Ozempic Cuts Risk of Major Cardiovascular Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2671321075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671321075?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:13","pubTimestamp":1790691203,"startTime":"0","endTime":"0","summary":"BRIEF-Novo Says Ozempic Cuts Risk Of Major Cardiovascular EventsSept 29 (Reuters)-Novo Nordisk A/SNOVOb.CO:NOVO'S OZEMPIC (SEMAGLUTIDE) 2 MG ASSOCIATED WITH LOWER RISK OF MAJOR ADVERSE CARDIOVASCULAR ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45K15E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LU1093756168.USD","THNR","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4588","BK4585","LU1093756325.SGD","PPH","BK4007","OZEM","LU0154236417.USD","BK4532","NVOC","BK4599","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210199","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671210199?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:40","pubTimestamp":1790689233,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Ax...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4532","AXSM","NVOH","BK4599","THNR","PPH","IE00BKVL7J92.USD","BK4007","CLPT","LU1093756325.SGD","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","NVOC","BK4585","BK4082","BK4588","LU1093756168.USD","BK4505","NVOX","NVO","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671212100","title":"AbbVie Partners with Valkai to Deploy AI Across Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671212100","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671212100?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:03","pubTimestamp":1790687000,"startTime":"0","endTime":"0","summary":"AbbVie partners with Valkai to deploy AI across clinical developmentAbbVie entered a partnership with Valkai to deploy AI tools across targeted areas of clinical development.Collaboration aims to impr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8NKYd1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU1934455863.HKD","MEDX","LU2089284900.SGD","LU0122379950.USD","IE00BLSP4452.SGD","LU0472753341.HKD","LU0689626769.HKD","LU0820561909.HKD","LU0859254822.USD","LU0310799852.SGD","LU1839511570.USD","IYH","LU1037948541.HKD","IE00B19Z3B42.SGD","FTXH","FHLC","LU0912757837.SGD","LU1496350502.SGD","IE000WAW04H5.SGD","IE00BBT3K403.USD","LU0211327993.USD","LU1670627923.USD","LU1923622614.USD","LU0057025933.USD","IE00B42XCP33.USD","PJP","JDOC","LU2125909593.SGD","LU2237443622.USD","ABBV","XLV","LU0417517546.SGD","TRUH","RXL","GLAM","IE00B19Z3581.USD","LU1236620750.USD","LU0289739343.SGD","VHT","LU1670628061.USD","AGNG","LU0310800379.SGD","IXJ","LU1244550577.SGD","LU1037948897.HKD","PPH","LU0211328371.USD","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":6,"totalSize":285,"code":"91000000","status":"200"}]}}